The enhanced anti-HCC ability of the ­combination of sorafenib with STAT3 knockdown was attributed to apoptosis induced by the DNA-cGAS-STING-type I IFNs axis in DCs [48]. Here, STAT3 is linked to hepatocellular carcinoma.